NCT02132052View on ClinicalTrials.gov

Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Essential TremorMultiple System AtrophyCorticobasal DegenerationSupranuclear Palsy, ProgressiveParkinson Disease
Trial Locations (1)

80045

University Of Colorado. Denver, MEG Lab, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02132052 - Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography. | Biotech Hunter | Biotech Hunter